DIANA DE FARMACOS EN CANDIDA ALBICANS

Una molécula de ácido nucleico, que consiste en mARN o cADN que codifica un polipéptido que es crítico para la supervivencia y crecimiento de la levadura Candida albicans, molécula de ácido nucleico que es al menos un 70% homóloga a la secuencia de nucleótidos ilustrada en la SEQ ID No 1. The presen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CONTRERAS, ROLAND H, VIAENE, JASMINE, ELZA, LOGGHE, MARC, GEORGE, LUYTEN, WALTER, HERMAN, MARIA, LOUIS, DE BACKER, MARIANNE, DENISE, NELISSEN, BART
Format:	Patent
Sprache:	spa
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Una molécula de ácido nucleico, que consiste en mARN o cADN que codifica un polipéptido que es crítico para la supervivencia y crecimiento de la levadura Candida albicans, molécula de ácido nucleico que es al menos un 70% homóloga a la secuencia de nucleótidos ilustrada en la SEQ ID No 1. The present invention is concerned with the identification of genes or functional fragments thereof from Candida albicans which are critical for growth and cell division and which genes may be used as selective drug targets to treat Candida albicans associated infections. Novel nucleic acid sequences from Candida albicans are also provided and which encode the polypeptides which are critical for growth of Candida albicans. Methods for the identification of anti-fungal compounds which inhibit fungal or yeast growth are also contemplated.